Page last updated: 2024-08-23

daunorubicin and dinaciclib

daunorubicin has been researched along with dinaciclib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Büküm, N; Flaxová, M; Hofman, J; Kouklíková, E; Louvarová, D; Novotná, E; Wsól, V	1

Other Studies

1 other study(ies) available for daunorubicin and dinaciclib

Article	Year
Aldo-keto reductase 1C3 (AKR1C3): a missing piece of the puzzle in the dinaciclib interaction profile. Archives of toxicology, 2018, Volume: 92, Issue:9 Topics: Aldo-Keto Reductase Family 1 Member C3; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cyclic N-Oxides; Daunorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; HCT116 Cells; Hep G2 Cells; Humans; Indolizines; Pyridinium Compounds; Recombinant Proteins	2018

Article

Year

Aldo-keto reductase 1C3 (AKR1C3): a missing piece of the puzzle in the dinaciclib interaction profile.

Archives of toxicology, 2018, Volume: 92, Issue:9

Topics: Aldo-Keto Reductase Family 1 Member C3; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cyclic N-Oxides; Daunorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; HCT116 Cells; Hep G2 Cells; Humans; Indolizines; Pyridinium Compounds; Recombinant Proteins

2018